Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meloxicam injection for postoperative abdominal surgery pain
ChiCTR2300074287Phase 2Not yet recruiting
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of meloxicam in postoperative pain (3 arms), sponsored by Third Xiangya Hospital, Central South University. Primary endpoint: Numerical Rating Scale pain intensity score. Planned start Aug 2023; status: not yet recruiting.
02
Drugs
meloxicam
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2300074287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300074287.